Cordlife Group Limited (CLIFF)
OTCMKTS · Delayed Price · Currency is USD
0.1721
0.00 (0.00%)
Aug 24, 2025, 8:00 PM EDT
Cordlife Group Market Cap
Cordlife Group has a market cap or net worth of $42.95 million as of August 26, 2025. Its market cap has decreased by -25.93% in one year.
Market Cap
42.95M
Enterprise Value
4.01M
Revenue
29.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since March 29, 2012, Cordlife Group's market cap has decreased from 81.39M to 42.95M, a decrease of -47.23%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 39.95M | 41.39% |
| Dec 30, 2024 | 28.26M | -53.80% |
| Dec 29, 2023 | 61.17M | 0.13% |
| Dec 30, 2022 | 61.09M | -19.10% |
| Dec 30, 2021 | 75.51M | -1.99% |
| Dec 31, 2020 | 77.04M | -12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |